加强免疫改善产前HBsAg暴露后HBsAg特异性Tfh细胞生成
本研究以模拟人类产前HBsAg暴露的小鼠模型,探讨产前HBsAg暴露对HBsAg特异性Tfh细胞和抗-HBs生成的影响。结果显示暴露小鼠HBsAg特异性CD4+CXCR5+PD1+Tfh细胞和CD138+IgD-浆细胞生成减少,而HBV疫苗加强免疫可改善Tfh细胞和浆细胞生成并增强抗-HBs产生,可能与IL-21产生增加有关。
要点
- 产前HBsAg暴露小鼠HBsAg特异性Tfh细胞和浆细胞生成减少。
- HBV疫苗加强免疫可改善暴露小鼠Tfh细胞和浆细胞生成及抗-HBs产生。
- IL-21补充可改善部分暴露小鼠的Tfh和浆细胞生成。
核心结论
- 产前HBsAg暴露导致HBsAg特异性Tfh细胞和浆细胞生成受损,HBV疫苗加强免疫可改善该损伤,可能通过增加IL-21产生。
研究设计与样本
- 将雌性Alb1-HBV(HBV-M)小鼠与雄性C57BL/6J小鼠交配,获得F1代HBV-M/F1+(肝组织和血液表达HBsAg)和HBV-M/F1-(羊水中暴露HBsAg)小鼠。
- F1代小鼠4周龄时皮下接种含5 μg HBsAg的乙型肝炎疫苗。
- 比较不同品系小鼠HBsAg特异性Tfh细胞和浆细胞生成,并进行Tfh细胞与B细胞共培养及IL-21补充实验。
主要发现
- 与C57BL/6J小鼠相比,HBV-M/F1-和HBV-M/F1+小鼠HBsAg特异性CD4+CXCR5+PD1+Tfh细胞和CD138+IgD-浆细胞生成均减少。
- 共培养实验表明,CD4+T细胞对HBsAg的活化应答对产前HBsAg暴露后抗-HBs生成至关重要。
- 补充IL-21可改善HBV-M/F1-小鼠HBsAg特异性Tfh和浆细胞生成,而对HBV-M/F1+小鼠效果不明显。
- 在HBV-M/F1-小鼠中,HBV疫苗加强免疫改善Tfh细胞和浆细胞生成并增强抗-HBs产生。
临床怎么用
- 对于产前HBsAg暴露者,HBV疫苗加强免疫可能改善HBsAg特异性Tfh细胞和浆细胞生成及抗-HBs应答。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Breakthrough infections of hepatitis B virus (HBV) after neonatal vaccination occurred in some adolescents and young adults who were born to mothers with hepatitis B surface antigen (HBsAg). We aimed to determine the impacts of prenatal HBsAg exposure on the generation of T follicular helper (Tfh) cells and antibodies (anti-HBs) specific to HBsAg. To mimic human prenatal HBsAg exposure, we mated female Alb1-HBV (HBV-M) mice with male C57BL/6J mice. Of their first filial generation (F1), HBV-M/F1+ expressed HBsAg in liver tissues and blood, and HBV-M/F1- mice exposed HBsAg in amniotic fluid. At their four weeks old, each HBV-M/F1 mouse was immunized with hepatitis B vaccine containing 5 μg HBsAg subcutaneously. Both HBV-M/F1- and HBV-M/F1+ mice had reduced generation of HBsAg-specific CD4+CXCR5+PD1+ Tfh cells and CD138+IgD- plasma cells in comparison with C57BL/6J mice. Results of coculturing the Tfh cells with B cells that were isolated from different strains of mice indicated that CD4+ T cell activation in response to HBsAg was critical for anti-HBs generation after prenatal HBsAg exposure. When interleukin (IL) 21 was supplemented, the generation of HBsAg-specific Tfh and plasma cells in HBV-M/F1- mice was improved, while supplementation showed little effect in HBV-M/F1+ mice. In HBV-M/F1- mice, HBV vaccine booster improved the generation of Tfh cells and plasma cells, and enhanced anti-HBs production. CONCLUSION: Impaired generation of HBsAg-specific Tfh cells and plasma cells after prenatal HBsAg exposure can be improved by HBV vaccine booster, most likely increasing IL-21 production.
引用
- Wang R, Chen K, Wang Y, et al. Booster immunization improves the generation of T follicular helper (Tfh) cells specific to hepatitis B surface antigen (HBsAg) after prenatal HBsAg exposure. Vaccine. 2021. PMID: 34412920. doi:10.1016/j.vaccine.2021.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。